Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001225208-14-012886)

Filing Details

Accession Number:: 0001225208-14-012886
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-05-13 17:28:10
Reporting Period:: 2014-05-09

Filing Date:: 2014-05-13
Accepted Time:: 2014-05-13 17:28:10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
810509	Navidea Biopharmaceuticals Inc.	NAVB	In Vitro & In Vivo Diagnostic Substances (2835)	311080091

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1278271	Jerome Mark Pykett	5600 Blazer Parkway Suite 200 Dublin OH 43017	Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-05-09	10,000	$1.34	292,674	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,851	Indirect	By 401(k)
Common Stock	1,100	Indirect	By IRA

Footnotes

The transaction is matchable under Section 16(b) of the Securities Exchange Act with Dr. Pykett's sale of 120,000 shares of common stock at $1.96 per share on March 10, 2014. As a result, Dr. Pykett will pay the company $6,200, representing the full amount of the profit realized in connection with the short-swing transaction.